These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10335)

  • 41. Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.
    Baker PJ; Amsbaugh DF; Stashak PW; Caldes G; Prescott B
    J Immunol; 1982 Mar; 128(3):1059-62. PubMed ID: 6173416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response.
    Moens L; Wuyts M; Meyts I; De Boeck K; Bossuyt X
    J Immunol; 2008 Oct; 181(8):5306-12. PubMed ID: 18832686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct demonstration of specific suppressor T cells in the mice tolerant to type III pneumococcal polysaccharide: two-step requirement for development of detectable suppressor cells.
    Braley-Mullen H
    J Immunol; 1980 Oct; 125(4):1849-54. PubMed ID: 6157748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
    Ambrosino DM; Schiffman G; Gotschlich EC; Schur PH; Rosenberg GA; DeLange GG; van Loghem E; Siber GR
    J Clin Invest; 1985 Jun; 75(6):1935-42. PubMed ID: 3924957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-cell mediated immunosuppression and its implications for the development of protective immunity.
    Baker PJ; Hraba T
    Folia Biol (Praha); 1994; 40(6):349-58. PubMed ID: 7589694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of IgG responses by helper and suppressor T cells activated by pneumococcal capsular polysaccharides.
    Milligan GN; Braley-Mullen H
    Cell Immunol; 1989 Mar; 119(1):222-32. PubMed ID: 2465833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigen requirements for priming of IgG producing B memory cells specific for Type III pneumococcal polysaccharide.
    Braley-Mullen H
    Immunology; 1980 Aug; 40(4):521-7. PubMed ID: 7000684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyl-lysine-substituted pneumococcal polysaccharide (SIII) and levan.
    Klaus GG; Humphrey JH
    Eur J Immunol; 1974 May; 4(5):370-7. PubMed ID: 4153121
    [No Abstract]   [Full Text] [Related]  

  • 49. Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice.
    Ekwunife FS; Taylor CE; Fauntleroy MB; Stashak PW; Baker PJ
    Infect Immun; 1991 Jun; 59(6):2192-4. PubMed ID: 1828058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jan; 112(1):404-9. PubMed ID: 4149590
    [No Abstract]   [Full Text] [Related]  

  • 51. Neonatal infection with mouse thymic virus: effects on cells regulating the antibody response to type III pneumococcal polysaccharide.
    Morse HC; Cross SS; Baker PJ
    J Immunol; 1976 Jun; 116(6):1613-7. PubMed ID: 5561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide.
    Baker PJ; Fauntleroy MB; Stashak PW; Hiernaux JR; Cantrell JL; Rudbach JA
    Infect Immun; 1989 Mar; 57(3):912-7. PubMed ID: 2783922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation.
    Braley-Mullen H
    J Immunol; 1976 Apr; 116(4):904-10. PubMed ID: 3609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective sensitivity to hydrocortisone of regulatory functions that determine the magnitude of the antibody response to type III pneumococcal polysaccharide.
    Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1978 Sep; 121(3):829-34. PubMed ID: 29068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of the antibody response to type 3 pneumococcal polysaccharide. 3. Role of regulatory T cells in the development of an IgG and IgA antibody response.
    Barthold DR; Prescott B; Stashak PW; Amsbaugh DF; Baker PJ
    J Immunol; 1974 Mar; 112(3):1042-50. PubMed ID: 4149561
    [No Abstract]   [Full Text] [Related]  

  • 56. Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells.
    Jones JM; Amsbaugh DF; Stashak PW; Prescott B; Baker PJ; Alling DW
    J Immunol; 1976 Mar; 116(3):647-56. PubMed ID: 3604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-cell dependent response to immune complexes abrogates B-cell unresponsiveness to pneumococcal cell wall polysaccharide.
    Caulfield MJ; Stanko D
    Immunology; 1995 Nov; 86(3):331-5. PubMed ID: 8550067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressor T cells and host resistance to tye 111 pneumococcus after treatment with antilymphocyte serum.
    Barth RF; Singla O; Liu C
    Infect Immun; 1975 Dec; 12(6):1307-12. PubMed ID: 1345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promotion of secondary anti-DNP antibody production in mice by type III pneumococcal polysaccharide (SIII) and dinitrophenylated rabbit antibody to SIII.
    Mitchell GF
    Immunology; 1975 Jul; 29(1):39-47. PubMed ID: 1095473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rabbit B spleen lymphocytes and T helper cells. I. Responsiveness to mitogens of B cell subpopulations of different sedimentation velocities and subpopulations bearing or lacking Fcgamma receptors.
    Cavaillon JM; Udupa TN; Chou CT; Cinader B; Haeffner-Cavaillon N; Dubiski S
    J Immunol; 1979 Nov; 123(5):2231-8. PubMed ID: 39964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.